ENGEL supports its customers in the maintenance of injection molding machines and linear robots with six configurable maintenance packages. Processing firms benefit from the ENGEL service engineers' ...

Research from the University of Oxford suggests that individuals stopping weight-loss injections, such as Mounjaro and ...

LEQEMBI IQLIK will be launched on October 6, 2025, in the U.S. TOKYO and CAMBRIDGE, Mass., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO ...

EBGLYSS 250 mg/2 mL injection is dosed as a single monthly maintenance injection following the initial phase of treatment. The recommended initial starting dose of EBGLYSS is 500 mg (two 250 mg ...

In a group of young users of injection drugs, recent maintenance opioid agonist therapy with methadone or buprenorphine for opioid use disorders, such as heroin addiction, was associated with a lower ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Patients with diabetic macular edema were able to maintain visual acuity improvements long term despite ...

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial ...

EBGLYSS is an interleukin-13 (IL-13) inhibitor that selectively blocks IL-13 signaling with high binding affinity. 2,3,4 The cytokine IL-13 is a primary cytokine in atopic dermatitis, driving the type ...

DENVER — Patients with diabetic macular edema were able to maintain visual acuity improvements long term despite receiving fewer anti-VEGF injections as treatment progressed, according to a study. At ...

Mar 07, 2025, 8:30 AM ET Among EBGLYSS Week 16 responders from the monotherapy trials, 50% achieved highest bar of complete skin clearance (EASI 100 or IGA 0) and 87% achieved almost-clear skin (EASI ...